SCHEMBL6167614

SCHEMBL6167614

COCc1cccc(CN2CCC(N3C(=O)Nc4ccccc4C3c3cccc(Cl)c3)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.44
CHRM3 P20309 4/20 0.44
OPRM1 P35372 2/20 0.44
DRD2 P14416 4/20 0.43
DRD4 P21917 4/20 0.43
DRD3 P35462 3/20 0.42
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SIGMAR1 Q99720 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166931 0.93 CHRM3 (0.43) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6167620 0.92 CHRM3 (0.41) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6168017 0.90 CHRM2 (0.44) CHRM2CHRM3OPRM1CYP2D6CYP2C9
SCHEMBL6169679 0.90 CHRM3 (0.48) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6170271 0.90 CHRM2 (0.45) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6166884 0.90 CHRM3 (0.51) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6169683 0.90 MEN1 (0.48) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6167790 0.88 CHRM2 (0.43) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6165720 0.88 CHRM3 (0.47) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL8564439 0.87 CHRM2 (0.55) CHRM2CHRM3OPRM1DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1122253-B1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMA (JP) 2005-08-17 EP disclosed
US-6645971-B1 Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2003-11-11 US disclosed
EP-1122253-A1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-08-08 EP disclosed